223 related articles for article (PubMed ID: 25430399)
1. Abnormal plasma sodium concentrations in patients treated with desmopressin for cranial diabetes insipidus: results of a long-term retrospective study.
Behan LA; Sherlock M; Moyles P; Renshaw O; Thompson CJ; Orr C; Holte K; Salehmohamed MR; Glynn N; Tormey W; Thompson CJ
Eur J Endocrinol; 2015 Mar; 172(3):243-50. PubMed ID: 25430399
[TBL] [Abstract][Full Text] [Related]
2. Central Diabetes Insipidus in Infancy With or Without Hypothalamic Adipsic Hypernatremia Syndrome: Early Identification and Outcome.
Djermane A; Elmaleh M; Simon D; Poidvin A; Carel JC; Léger J
J Clin Endocrinol Metab; 2016 Feb; 101(2):635-43. PubMed ID: 26588450
[TBL] [Abstract][Full Text] [Related]
3. The Impact of a Standardized Sodium Protocol on Incidence and Outcome of Dysnatremias in Neurocritical Care.
Spatenkova V; Bradac O; Skrabalek P
J Neurol Surg A Cent Eur Neurosurg; 2015 Jul; 76(4):279-90. PubMed ID: 25539069
[TBL] [Abstract][Full Text] [Related]
4. Management of Central Diabetes Insipidus in Disabled Children with Diluted Oral Desmopressin Lyophilisate Formulation Administered Through Nasogastric Tube: A Retrospective Case Series.
Korkmaz HA; Arya VB; Gönüllü A; Coşkunol F; Ozkan B
Paediatr Drugs; 2023 Sep; 25(5):595-601. PubMed ID: 37326929
[TBL] [Abstract][Full Text] [Related]
5. Abnormal regulation of thirst and vasopressin secretion following surgery for craniopharyngioma.
Smith D; Finucane F; Phillips J; Baylis PH; Finucane J; Tormey W; Thompson CJ
Clin Endocrinol (Oxf); 2004 Aug; 61(2):273-9. PubMed ID: 15272926
[TBL] [Abstract][Full Text] [Related]
6. Successful treatment of hypernatremic thirst deficiency with chlorpropamide.
Nandi M; Harrington AR
Clin Nephrol; 1978 Sep; 10(3):90-5. PubMed ID: 699408
[TBL] [Abstract][Full Text] [Related]
7. [Clinical characteristics of 7 patients with gestational diabetes insipidus].
Wu LQ; Xiong CQ; Wu M; Dong RL; Chen YQ; Gao J; Chen OJ; Huang YP
Zhonghua Fu Chan Ke Za Zhi; 2008 Apr; 43(4):266-8. PubMed ID: 18843966
[TBL] [Abstract][Full Text] [Related]
8. Hypernatraemia due to a reset osmostat for vasopressin release and thirst, complicated by nephrogenic diabetes insipidus.
Thompson CJ; Freeman J; Record CO; Baylis PH
Postgrad Med J; 1987 Nov; 63(745):979-82. PubMed ID: 3451225
[TBL] [Abstract][Full Text] [Related]
9. Low-dose desmopressin combined with serum sodium monitoring can prevent clinically significant hyponatraemia in patients treated for nocturia.
Juul KV; Malmberg A; van der Meulen E; Walle JV; Nørgaard JP
BJU Int; 2017 May; 119(5):776-784. PubMed ID: 27862898
[TBL] [Abstract][Full Text] [Related]
10. Essential hypernatremia: disordered thirst and blood pressure control.
Brown MA; Mullins R; Stokes GS; Györy AZ
Aust N Z J Med; 1985 Dec; 15(6):751-4. PubMed ID: 3869442
[TBL] [Abstract][Full Text] [Related]
11. Desmopressin administration in children with central diabetes insipidus: a retrospective review.
Ooi HL; Maguire AM; Ambler GR
J Pediatr Endocrinol Metab; 2013; 26(11-12):1047-52. PubMed ID: 23843580
[TBL] [Abstract][Full Text] [Related]
12. Management of cranial diabetes insipidus: clinical outcomes and patient perception of care.
Dilrukshi MDSA; Vickars M; May CJH; Makaya T; Ryan F; Jafar-Mohammadi B; Wass JAH; Pal A; Garrahy A
Eur J Endocrinol; 2022 Sep; 187(3):489-495. PubMed ID: 35900310
[TBL] [Abstract][Full Text] [Related]
13. Comparison of incidence of hyponatremia between intranasal and oral desmopressin in patients with central diabetes insipidus.
Kataoka Y; Nishida S; Hirakawa A; Oiso Y; Arima H
Endocr J; 2015; 62(2):195-200. PubMed ID: 25382102
[TBL] [Abstract][Full Text] [Related]
14. ENDOCRINOLOGY IN THE TIME OF COVID-19: Management of diabetes insipidus and hyponatraemia.
Christ-Crain M; Hoorn EJ; Sherlock M; Thompson CJ; Wass JAH
Eur J Endocrinol; 2020 Jul; 183(1):G9-G15. PubMed ID: 32380474
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors for impaired plasma sodium homeostasis after transsphenoidal surgery.
Staiger RD; Sarnthein J; Wiesli P; Schmid C; Bernays RL
Br J Neurosurg; 2013 Feb; 27(1):63-8. PubMed ID: 22905890
[TBL] [Abstract][Full Text] [Related]
16. Management of central diabetes insipidus.
Garrahy A; Thompson CJ
Best Pract Res Clin Endocrinol Metab; 2020 Sep; 34(5):101385. PubMed ID: 32169331
[TBL] [Abstract][Full Text] [Related]
17. Clinical insights into adipsic diabetes insipidus: a large case series.
Crowley RK; Sherlock M; Agha A; Smith D; Thompson CJ
Clin Endocrinol (Oxf); 2007 Apr; 66(4):475-82. PubMed ID: 17371462
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic approach in patients with dysnatraemias.
Liamis G; Kalogirou M; Saugos V; Elisaf M
Nephrol Dial Transplant; 2006 Jun; 21(6):1564-9. PubMed ID: 16449285
[TBL] [Abstract][Full Text] [Related]
19. [Home monitoring of sodium in children with adipsic diabetes insipidus].
Peinado Barraso MC; García García E
An Pediatr (Engl Ed); 2020 Oct; 93(4):262-264. PubMed ID: 32057712
[No Abstract] [Full Text] [Related]
20. Hyperuricemia as a clue for central diabetes insipidus (lack of V1 effect) in the differential diagnosis of polydipsia.
Decaux G; Prospert F; Namias B; Soupart A
Am J Med; 1997 Nov; 103(5):376-82. PubMed ID: 9375705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
